Tag: patent litigation

Despite FDA approval, generic drugs in the U.S. face average delays of 3.2 years due to patent litigation, with complex drugs and oncology treatments hit hardest. Learn how patent thickets, the 30-month stay, and supply chain issues block affordable access.